Poll: Only Half of Older Adults Have Heard of the New RSV Vaccines, Arexvy and Abrysvo
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
MONDAY, Aug. 28, 2023 -- About half of older adults (52 percent) have heard of the new vaccines against respiratory syncytial virus (RSV), Arexvy and Abrysvo, according to the National Poll on Healthy Aging released online on Aug. 22.
The poll, which comes from the University of Michigan in Ann Arbor, was administered July 17 through Aug. 7 to 1,850 people aged 60 to 80 years.
The poll showed that 21 percent of respondents said they were very interested, and another 43 percent said they were somewhat interested. However, only 41 percent of older adults who reported their health as fair or poor had heard of the RSV vaccines versus 53 percent of those who rated their health as good to excellent. Regardless of whether or not they had previously heard of the vaccines before the poll, more than 65 percent of those with a chronic health condition said they were very or somewhat interested in getting an RSV vaccine.
"As we prepare for the first RSV season when vaccines will be available for older adults, these early data suggest a need for public health officials, primary care providers, pharmacies, and others to target their outreach and awareness-building efforts," poll senior advisor Preeti Malani, M.D., from the University of Michigan, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Vaccines Will Be Best Defense Against Bird Flu, Experts Say
WEDNESDAY, May 29, 2024 -- Humanity’s best protection against bird flu will be the development of effective vaccines, a new study says. The H5N1 avian flu has been raging...
Scientists Developing mRNA-Based Vaccine Against H5N1 Bird Flu
TUESDAY, May 28, 2024 -- An experimental mRNA vaccine against the H5N1 avian flu is highly effective in preventing severe illness and death in lab animals, researchers...
HPV Vaccine Is Also Preventing Cancers in Men: Study
FRIDAY, May 24, 2024 -- Development and uptake of the human papilloma virus (HPV) vaccine has been crucial in reducing rates of virus-linked cervical cancers in women. Now, the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
